【作者单位】1Qian Xuesen Collaborative Research Center of Astrochemistry and Space Life Sciences, Institute of Drug Discovery Technology, Ningbo University, 315211, Ningbo, Zhejiang Province, China;2Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, Fudan University School of Pharmacy, 201203, Shanghai, China;3Bioinformatics and Drug Design Group, Department of Pharmacy, National University of Singapore, 117543, Singapore, Singapore;4Medical College, Tibet University, 850011, Lhasa, China;5Department of Chemical Biology, College of Chemistry and Chemical Engineering, and The Key Laboratory for Chemical Biology of Fujian Province, Xiamen University, 361005, Xiamen, Fujian Province, China;6Key Laboratory of Bioorganic Phosphorus Chemistry and Chemical Biology (Ministry of Education), Department of Chemistry, Tsinghua University, 102206, Beijing, China
【年份】2022
【卷号】Vol.28 No.7
【页码】627-635
【ISSN】1672-0415
【关键词】COVID-19 Chinese medicine target therapeutic mechanism pathophysiology comorbidity
【摘要】 Objective To investigate how the National Health Commission of China -recommended Chinese medicines modulate the major maladjustments of coronavirus disease 2019 , particularly the clinically observed complications and comorbidities. Methods By f...
